#Champions Awards 2017

3rd January 2018


 

The #CLChampions Awards for 2017 was held at Hotel du Vin in December with over 80 members of the #CLFamily enjoying afternoon tea and a celebration of their efforts this year! There were emotional and empassioned speeches from Co-Founder Professor Charlie Craddock CBE, Chairman Ian Allen and CEO James McLaughlin as the total raised by just those in room was announced as £781,656.53. The winner in the various categories are listed below:

 

 

The Chairman's Award

Wolverhampton Wanderers FC & Steve Plant

 

 

 

Wackiest Fundraiser Of The Year

Liz & Adam Rudkin

 

 

 

Young Fundraiser Of The Year

Robert Ward

 

 

 

Community Fundraiser Of The Year

The Littell Family

 

 

 

Just One More Award

Pat Murphy & The 'Andy Payne Fund A Nurse' Committe

 

 

 

Individual Of The Year

Mark Nicholas

 

 

 

Team Of The Year

The Price Family & Friends

 

 

 

Corporate Partner Of The Year

The Binding Site

 

 

 

Volunteer Of The Year

Everyone won! Matilda Elwell, John & Deborah Riley, Steve & Patricia Shaw, Lisa O'Keeffe, Ant Hoye & Zara Rikalans

 

 

Special Recognition Award

Malmaison Birmingham

 

 

 

Special Recognition Award

Jessica Hempshall

 

 

 

Special Recognition Award

Elonex Outdoor Media

 

 

 

Unsung Hero Award

Ben Foster

 

 

 

Cure Leukaemia Nurses Award

Lizzie Dean

 

 

 

£1m Centre Appeal Award

The 3 Tours Challenge Team: Doug McKinnon, Geoff Thomas, James Maltin & Hayden Groves

 

 

 

If you've missed out this year remember look out for nominations for the 2018 awards! Enjoy the full photo album from the event below.

 

#CLChampions Awards 2017

< Back to List

What we do

The Trials Acceleration Programme (TAP)

How funds raised for Cure Leukaemia help save lives

Cure Leukamia Pre footer image
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell